查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1645729

全球疏水交互作用层析法市场（按产品/服务、样品类型、应用和最终用户划分）- 机会分析和行业预测，2024 年至 2033 年

Hydrophobic Interaction Chromatography Market By Product and Service, By Sample type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 412 Pages | 商品交期: 2-3个工作天内

价格
简介目录

疏水交互作用层析法市场

疏水性相互作用色谱市场-IMG1

疏水交互作用层析法市场规模在 2023 年预计为 4.6189 亿美元，预计到 2033 年将达到 9.5293 亿美元，2024 年至 2033 年的复合年增长率为 7.5%。

疏水交互作用层析法(HIC) 是一种生物分子分离技术，可根据蛋白质和其他生物分子的疏水性将其区分。 HIC的运行原理是蛋白质在流动相离子强度的影响下可逆地与固定基质上的疏水基团结合。此技术可应用于生物技术和製药行业中的抗体分离、蛋白质精製和疏水化合物的分离。

疏水交互作用层析法市场主要受到全球生物製药行业扩张的推动，因为在药物和疫苗开发过程中需要使用疏水性相互作用色谱。此外，政府和私人组织对生物技术和研究的投资不断增加，推动了市场的成长。疏水交互作用层析法市场的一个显着趋势是在食品和营养保健品行业中使用 HIC。 HIC用于分离和精製蛋白质和胜肽，以改善其口感和营养价值。

然而，由于该技术无法扩大规模以满足广泛的精製要求，其市场发展受到阻碍。此外，HIC是一种相对耗时的技术，面临着亲和色谱和离子交换层析法等替代技术的激烈竞争。这降低了 HIC 的效用并严重抑制了市场成长。另一方面，生物创投公司的增加和投资的激增预计将为疏水交互作用层析法市场提供有利的成长机会。麦肯锡的资料显示，针对生物新兴企业的创业投资从 2016 年的 2,200 笔增加到了 2021 年的 3,100 笔。此外，2021 年初新兴企业将在全球筹集超过 340 亿美元的资金，是 2020 年 160 亿美元总额的两倍多。预计投资的激增将推动蛋白质和分子生物学相关研究的增加，从而增加对先进 HIC 设备的需求。

审查细分

疏水交互作用层析法市场细分为产品/服务、样品类型、应用、最终用户和地区。根据产品/服务，市场分为产品和服务。产品部分进一步分为树脂、缓衝液、管柱和其他。树脂部分又分为珠子和其他。管柱段又分为预装管柱和空管柱。预填充管柱段进一步分为抛弃式或可重复使用。依样本类型，市场分为单株抗体、疫苗、细胞培养样本、血浆和血清样本等。根据应用，分为蛋白质和抗体精製、疫苗开发、药物发现以及食品和营养补充剂开发。蛋白质和抗体精製领域根据树脂分为珠子和其他。就最终用户而言，市场分为製药和生物製药公司、受託研究机构和契约製造组织、研究和学术机构等。根据地区，市场分析为北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙和其他欧洲国家）、亚太地区（日本、中国、印度、澳洲、韩国和亚太其他地区）、拉丁美洲、中东和非洲（巴西、中国、印度、澳洲、韩国、拉丁美洲其他地区、中东和非洲）。

主要发现

根据产品/服务，该产品细分市场在 2023 年占据了市场占有率的主导地位。

从样本类型来看，单株抗体领域占比较大。

根据应用，蛋白质和抗体精製部分在 2023 年占据最高的市场占有率。

根据最终用户，製药和生物製药公司在 2023 年占据最高份额。

按地区划分，预计北美将在 2023 年创造最高收益。

相关人员的主要利益

该报告定量提供了 2023 年至 2033 年疏水交互作用层析法市场分析的市场细分、当前趋势、估计和趋势分析，并确定了主要的疏水交互作用层析法市场机会。

它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。

波特五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的商业决策，并加强供应商-买家网络。

详细分析疏水交互作用层析法市场细分有助于发现市场机会。

每个地区的主要国家都根据收益贡献进行划分。

市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。

它包括区域和全球疏水交互作用层析法市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化（需支付额外费用和时间表）

  • 国家、地区和全球层面的患者/流行病学资料
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 扩展公司简介列表
  • 历史市场资料
  • SWOT 分析

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 关键影响因素
    • 重大投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 生物製药研发成本不断增加
      • 对生技药品和单株抗体 (mAb) 的需求不断增加
      • 生物相似药的采用日益增多
    • 限制因素
      • 熟练劳动力短缺
      • 初期投资及营运成本高
    • 机会
      • 新兴市场的成长机会
      • 疏水交互作用层析法（HIC）技术进步

第 4 章疏水交互作用层析法市场（按产品和服务）

  • 概述
  • 产品
    • 疏水交互作用层析法市场（按产品类型）
      • 疏水交互作用层析法市场（按类型）
      • 管柱疏水交互作用层析法市场（按类型）
      • 预装管柱疏水交互作用层析法市场（按类型）
  • 服务

第 5 章疏水交互作用层析法市场（按样品类型）

  • 概述
  • 单株抗体
  • 疫苗
  • 细胞培养样本
  • 血浆和血清样本
  • 其他的

第六章疏疏水交互作用层析法市场（依应用）

  • 概述
  • 蛋白质和抗体精製
    • 疏水性疏水交互作用层析法市场，用于树脂精製蛋白质和抗体
  • 疫苗研发
  • 药物研发
  • 食品和营养补充品开发

第 7 章疏疏水交互作用层析法市场：按最终用户

  • 概述
  • 製药和生物製药公司
  • 受託研究机构/契约製造组织
  • 研究和学术机构
  • 其他的

第 8 章疏水交互作用层析法市场（按区域）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 南非
    • 沙乌地阿拉伯
    • 其他的

第九章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第十章 公司简介

  • Bio-Rad Laboratories, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Geno Technology, Inc.
  • Danaher Corporation
  • Sepax Technologies, Inc.
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Waters Corporation
  • KNAUER Wissenschaftliche Gerate GmbH
简介目录
Product Code: A325383

Hydrophobic Interaction Chromatography Market

Hydrophobic Interaction Chromatography Market - IMG1

The hydrophobic interaction chromatography market was valued at $461.89 million in 2023 and is estimated to reach $952.93 million by 2033, exhibiting a CAGR of 7.5% from 2024 to 2033.

Hydrophobic interaction chromatography (HIC) is a biomolecular separation technique that differentiates proteins and other biomolecules depending on their hydrophobicity. The working principle of HIC involves the reversible binding of proteins to hydrophobic groups on a stationary phase, under the influence of ionic strength of a mobile phase. The technique finds application in antibody isolation, protein purification, and separation of hydrophobic compounds in biotechnological & pharmaceutical industries.

The expanding biopharmaceutical industry across the globe is a key driver of the hydrophobic interaction chromatography market as it utilizes HIC in the development process of medicines and vaccines. In addition, rise in investments in the biotechnology & research sector by governments and private organizations has propelled the growth of the market. A notable trend acquiring traction in the hydrophobic interaction chromatography market is the use of HIC in the food and dietary supplement industries. They utilize HIC to improve taste and nutritional value by the separation & purification of proteins and peptides.

However, the inability of the technique scale-up and cater to extensive purification requirements hampers the development of the market. Furthermore, HIC is a relatively time-consuming technique and faces stringent competition from alternatives such as affinity & ion-exchange chromatography. This reduces the utility of HIC and restrains the market growth significantly. On the contrary, increase in the number of biotech start-ups and surge in investments in them is expected to present lucrative growth opportunities for the hydrophobic interaction chromatography market. McKinsey data states that investments by venture capital firms increased from 2,200 biotech start-ups globally in 2,016 to 3,100 in 2021. Moreover, the start-ups collected more than $34 billion globally in 2021, which was more than double the 2020 total of $16 billion. This upsurge in investments is anticipated to increase protein- and molecular biology-related research, fueling the requirement for advanced HIC equipment.

Segment Review

The hydrophobic interaction chromatography market is segmented into product & service, sample type, application, end user, and region. By product & service, the market is bifurcated into product and service. The product segment is further categorized into resin, buffer, column, and others. The resin segment is further bifurcated into beads and others. The column segment is further divided into pre-packed columns and empty columns. The pre-packed column segment is further categorized into disposable and reusable. Depending on sample type, the market is segregated into monoclonal antibodies, vaccines, cell culture sample, plasma & serum sample, and others. As per application, it is classified into protein & antibody purification, vaccine development, drug discovery, and food & dietary supplement development. The protein & antibody purification segment is further categorized for resins into beads and others. According to end user, the market is categorized into pharmaceutical & biopharmaceutical companies, contract research organizations & contract manufacturing organizations, research & academic institutes, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings

By product & service, the product segment dominated the market share in 2023.

Depending on sample type, the monoclonal antibodies segment held a high share of the market.

As per application, the protein & antibody purification segment accounted for the highest market share in 2023.

According to end user, the pharmaceutical & biopharmaceutical companies segment was the highest shareholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global hydrophobic interaction chromatography market are Bio-Rad Laboratories, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Tosoh Corporation, Danaher Corporation, Sepax Technologies, Inc., Agilent Technologies, Inc., Merck KGaA, Waters Corporation, and KNAUER Wissenschaftliche Gerate GmbH. These major players have adopted integration, product launch, contract, partnership, and expansion as their key strategies to expand their product portfolio.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hydrophobic interaction chromatography market analysis from 2023 to 2033 to identify the prevailing hydrophobic interaction chromatography market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the hydrophobic interaction chromatography market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global hydrophobic interaction chromatography market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product and Service

  • Product
    • Type
    • Resin

◦ Type

    • Buffer
    • Column

◦ Type

    • Others
  • Service

By Sample type

  • Monoclonal antibodies
  • Vaccines
  • Cell culture sample
  • Plasma and serum sample
  • Others

By Application

  • Protein and antibody purification
    • Resins
    • Beads
    • Others
  • Vaccine development
  • Drug discovery
  • Food and dietary supplement development

By End user

  • Research and academic institutes
  • Others
  • Pharmaceutical and biopharmaceutical companies
  • Contract research organizations and contract manufacturing organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Sepax Technologies, Inc.
    • Tosoh Corporation
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Geno Technology, Inc.
    • Waters Corporation
    • KNAUER Wissenschaftliche Gerate GmbH
    • Bio-Rad Laboratories, Inc.
    • Sartorius AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate intensity of rivalry
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of new entrants
    • 3.3.4. Moderate bargaining power of suppliers
    • 3.3.5. Moderate threat of substitutes
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in R&D expenditure in biopharmaceuticals
      • 3.4.1.2. Rise in demand for biologics and monoclonal antibodies (mAbs)
      • 3.4.1.3. Rise in adoption of biosimilars
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of a skilled workforce
      • 3.4.2.2. High initial investment and operating costs
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
      • 3.4.3.2. Technological advancements in hydrophobic interaction chromatography (HIC)

CHAPTER 4: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY PRODUCT AND SERVICE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Product
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Product Hydrophobic Interaction Chromatography Market by Type
      • 4.2.4.1. Resin Hydrophobic Interaction Chromatography Market by Type
      • 4.2.4.2. Column Hydrophobic Interaction Chromatography Market by Type
      • 4.2.4.2.1. Pre packed Columns Hydrophobic Interaction Chromatography Market by Type
  • 4.3. Service
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY SAMPLE TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Monoclonal antibodies
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Vaccines
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cell culture sample
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Plasma and serum sample
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Protein and antibody purification
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
    • 6.2.4. Protein and antibody purification Hydrophobic Interaction Chromatography Market by Resins
  • 6.3. Vaccine development
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Drug discovery
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Food and dietary supplement development
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Pharmaceutical and biopharmaceutical companies
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Contract research organizations and contract manufacturing organizations
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Research and academic institutes
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Others
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Product and Service
    • 8.2.3. Market size and forecast, by Sample type
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End user
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Product and Service
      • 8.2.6.1.2. Market size and forecast, by Sample type
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End user
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Product and Service
      • 8.2.6.2.2. Market size and forecast, by Sample type
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End user
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Product and Service
      • 8.2.6.3.2. Market size and forecast, by Sample type
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End user
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Product and Service
    • 8.3.3. Market size and forecast, by Sample type
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End user
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Product and Service
      • 8.3.6.1.2. Market size and forecast, by Sample type
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End user
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Product and Service
      • 8.3.6.2.2. Market size and forecast, by Sample type
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End user
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Product and Service
      • 8.3.6.3.2. Market size and forecast, by Sample type
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End user
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Product and Service
      • 8.3.6.4.2. Market size and forecast, by Sample type
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End user
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Product and Service
      • 8.3.6.5.2. Market size and forecast, by Sample type
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End user
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Product and Service
      • 8.3.6.6.2. Market size and forecast, by Sample type
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End user
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Product and Service
    • 8.4.3. Market size and forecast, by Sample type
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End user
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Product and Service
      • 8.4.6.1.2. Market size and forecast, by Sample type
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End user
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Product and Service
      • 8.4.6.2.2. Market size and forecast, by Sample type
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End user
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Product and Service
      • 8.4.6.3.2. Market size and forecast, by Sample type
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End user
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Product and Service
      • 8.4.6.4.2. Market size and forecast, by Sample type
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End user
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Product and Service
      • 8.4.6.5.2. Market size and forecast, by Sample type
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End user
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Product and Service
      • 8.4.6.6.2. Market size and forecast, by Sample type
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End user
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Product and Service
    • 8.5.3. Market size and forecast, by Sample type
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End user
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Product and Service
      • 8.5.6.1.2. Market size and forecast, by Sample type
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End user
      • 8.5.6.2. South Africa,
      • 8.5.6.2.1. Market size and forecast, by Product and Service
      • 8.5.6.2.2. Market size and forecast, by Sample type
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End user
      • 8.5.6.3. Saudi Arabia
      • 8.5.6.3.1. Market size and forecast, by Product and Service
      • 8.5.6.3.2. Market size and forecast, by Sample type
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End user
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Product and Service
      • 8.5.6.4.2. Market size and forecast, by Sample type
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End user

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Bio-Rad Laboratories, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
  • 10.2. Sartorius AG
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
    • 10.3.7. Key strategic moves and developments
  • 10.4. Tosoh Corporation
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. Geno Technology, Inc.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Danaher Corporation
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Sepax Technologies, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
  • 10.8. Agilent Technologies, Inc.
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
  • 10.9. Merck KGaA
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Waters Corporation
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments
  • 10.11. KNAUER Wissenschaftliche Gerate GmbH
    • 10.11.1. Company overview
    • 10.11.2. Key executives
    • 10.11.3. Company snapshot
    • 10.11.4. Operating business segments
    • 10.11.5. Product portfolio